Human BSAP and BLIMP1 conform an autoregulatory feedback loop.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 17682124)

Published in Blood on August 06, 2007

Authors

Francisco Mora-López1, Elena Reales, José A Brieva, Antonio Campos-Caro

Author Affiliations

1: Unidad de Investigación, Hospital Universitario Puerta del Mar, Avenida Ana de Viya 21, 11009 Cádiz, Spain.

Articles citing this

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell (2010) 2.73

New insights into the regulation of human B-cell differentiation. Trends Immunol (2009) 1.26

Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation. Mol Cell Biol (2009) 1.00

The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci (2010) 1.00

A replicative self-renewal model for long-lived plasma cells: questioning irreversible cell cycle exit. Front Immunol (2013) 0.99

Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Toxicol Sci (2009) 0.94

A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci (2010) 0.88

The role of the aryl hydrocarbon receptor in normal and malignant B cell development. Semin Immunopathol (2013) 0.84

Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin. BMC Syst Biol (2010) 0.83

Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis. Proc Natl Acad Sci U S A (2012) 0.80

Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1. Sci Rep (2015) 0.79

All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2013) 0.78

A Network Model to Describe the Terminal Differentiation of B Cells. PLoS Comput Biol (2016) 0.75

The transcriptional profiling of human in vivo-generated plasma cells identifies selective imbalances in monoclonal gammopathies. PLoS One (2017) 0.75

Articles by these authors

The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood (2002) 2.11

Inorganic polyphosphate and specific induction of apoptosis in human plasma cells. Haematologica (2006) 1.93

Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway. Stem Cells (2006) 1.27

Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis (2003) 1.21

Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J Immunol (2006) 0.99

Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther (2010) 0.96

Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies. Blood (2007) 0.93

Transcription of PRDM1, the master regulator for plasma cell differentiation, depends on an SP1/SP3/EGR-1 GC-box. Eur J Immunol (2008) 0.90

Determinants of the anesthetic sensitivity of neuronal nicotinic acetylcholine receptors. J Biol Chem (2001) 0.87

The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells. Haematologica (2007) 0.87

Higher maturity and connective tissue association distinguish resident from recently generated human tonsil plasma cells. J Leukoc Biol (2007) 0.86

Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: role of CXCR4-CXCL12 in lymphoid recruitment. Atherosclerosis (2008) 0.85

STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion. J Immunol (2013) 0.85

Transcription factors NF-Y and Sp1 are important determinants of the promoter activity of the bovine and human neuronal nicotinic receptor beta 4 subunit genes. J Biol Chem (2001) 0.84

A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm Bowel Dis (2005) 0.84

Identification of soluble N-ethylmaleimide-sensitive factor attachment protein receptor exocytotic machinery in human plasma cells: SNAP-23 is essential for antibody secretion. J Immunol (2005) 0.83

Cutting edge: IL-21 derived from human follicular helper T cells acts as a survival factor for secondary lymphoid organ, but not for bone marrow, plasma cells. J Immunol (2012) 0.82

CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints. Rheumatology (Oxford) (2006) 0.81

Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment. Br J Haematol (2002) 0.79

Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection. Thyroid (2004) 0.79

The expression of PRDI-BF1 beta isoform in multiple myeloma plasma cells. Haematologica (2006) 0.79

Syntaxin-4 is implicated in the secretion of antibodies by human plasma cells. J Leukoc Biol (2013) 0.78

NOA36 protein contains a highly conserved nucleolar localization signal capable of directing functional proteins to the nucleolus, in mammalian cells. PLoS One (2013) 0.77

Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape. Leuk Lymphoma (2002) 0.77

Modulated selection of IGHV gene somatic hypermutation during systemic maturation of human plasma cells. J Leukoc Biol (2009) 0.76

Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation. Immunol Lett (2010) 0.75